148 related articles for article (PubMed ID: 37046323)
1. Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study.
Tomah S; Salah T; Al-Badri M; Dhaver S; Gardner H; Tasabehji MW; Hamdy O
Clin Diabetes Endocrinol; 2023 Apr; 9(1):3. PubMed ID: 37046323
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China.
Liu Z; Jin P; Liu Y; Zhang Z; Wu X; Weng M; Cao S; Wang Y; Zeng C; Yang R; Liu C; Sun P; Tian C; Li N; Zeng Q
Nutr J; 2024 Jun; 23(1):64. PubMed ID: 38872173
[TBL] [Abstract][Full Text] [Related]
3. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.
Lazo M; Solga SF; Horska A; Bonekamp S; Diehl AM; Brancati FL; Wagenknecht LE; Pi-Sunyer FX; Kahn SE; Clark JM;
Diabetes Care; 2010 Oct; 33(10):2156-63. PubMed ID: 20664019
[TBL] [Abstract][Full Text] [Related]
4. Obesity, but not glycemic control, predicts liver steatosis in children with type 1 diabetes.
Tas E; Bai S; Mak D; Diaz EC; Dranoff JA
J Diabetes Complications; 2022 Dec; 36(12):108341. PubMed ID: 36345110
[TBL] [Abstract][Full Text] [Related]
5. Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one-year retrospective matched cohort study.
Mottalib A; Tomah S; Hafida S; Elseaidy T; Kasetty M; Ashrafzadeh S; Hamdy O
Diabetes Obes Metab; 2019 Jan; 21(1):37-42. PubMed ID: 30047220
[TBL] [Abstract][Full Text] [Related]
6. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.
Singh A; Le P; Lopez R; Alkhouri N
Hepatol Int; 2018 Jan; 12(1):37-43. PubMed ID: 29318450
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes.
de Vries M; El-Morabit F; van Erpecum KJ; Westerink J; Bac ST; Kaasjager HAHK; de Valk HW
Eur J Intern Med; 2022 Jun; 100():77-82. PubMed ID: 35387749
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients.
Bischoff M; Zimny S; Feiner S; Sauter J; Sydor S; Denk G; Nagel JM; Bischoff G; Rust C; Hohenester S
Eur J Nutr; 2022 Aug; 61(5):2725-2735. PubMed ID: 35277756
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
Sae-Wong J; Chaopathomkul B; Phewplung T; Chaijitraruch N; Sahakitrungruang T
J Pediatr; 2021 Mar; 230():32-37.e1. PubMed ID: 33250172
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
Guo W; Tian W; Lin L; Xu X
Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
[TBL] [Abstract][Full Text] [Related]
11. Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes.
Fennoun H; Mansouri SE; Tahiri M; Haraj NE; Aziz SE; Hadad F; Hliwa W; Badr W; Chadli A
Pan Afr Med J; 2020; 37():270. PubMed ID: 33598084
[TBL] [Abstract][Full Text] [Related]
12. The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care.
Hofmann WP; Buggisch P; Schubert L; Dikopoulos N; Schwenzer J; Muche M; Felten G; Heyne R; Ingiliz P; Schmidt A; Stein K; Wedemeyer H; Berg T; Wiegand J; Lammert F; Zeuzem S; Schattenberg JM
JHEP Rep; 2020 Dec; 2(6):100168. PubMed ID: 32964201
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
[TBL] [Abstract][Full Text] [Related]
14. The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis.
Alkharaiji M; Anyanwagu U; Crabtree T; Idris I
Surg Obes Relat Dis; 2021 Apr; 17(4):792-798. PubMed ID: 33676874
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity.
Jagtap N; Kalapala R; Katakwar A; Sharma M; Aslam M; Gupta R; Rao PN; Goud R; Tandan M; Kanakagiri H; Darishetty S; Reddy DN
Indian J Gastroenterol; 2021 Dec; 40(6):572-579. PubMed ID: 34914039
[TBL] [Abstract][Full Text] [Related]
16. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
[TBL] [Abstract][Full Text] [Related]
17. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
[TBL] [Abstract][Full Text] [Related]
20. Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes.
Reginato E; Pippi R; Aiello C; Sbroma Tomaro E; Ranucci C; Buratta L; Bini V; Marchesini G; De Feo P; Fanelli C
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31207986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
